Implantable intraocular drug delivery apparatus, system and method
View Patent ↗The present invention relates to an apparatus, system and method for, and for providing, intraocular delivery of an active agent. The apparatus, system and method may include an implantable scaffold and an active agent associated with the implantable scaffold. The implantable scaffold and the active agent may be configured to be completely contained within the eye upon implantation. The implantable scaffold may be a mechanical scaffold, or the implantable scaffold may be a chemical scaffold.
1. A method of providing intraocular delivery of an active agent in an eye, comprising:
providing an implantable scaffold, wherein the scaffold comprises an interior reservoir and is formed from a flexible material, wherein the scaffold comprises a mechanical scaffold in the shape of a closed ring;
associating the active agent with the scaffold;
performing an intraocular implantation of the scaffold and the active agent;
positioning an external reservoir configured to be positioned outside of the eye when the scaffold is intraocularly implanted, wherein the external reservoir is separate from the scaffold and comprises an injection port;
fluidly connecting the external reservoir to the interior reservoir via a tube;
delivering the active agent from the scaffold following the intraocular implantation; and
refilling the interior reservoir with the active agent via the injection port of the external reservoir after the intraocular implantation.
2. The method of claim 1 , wherein associating the active agent with the scaffold comprises filling at least a portion of the mechanical scaffold with the active agent.
3. The method of claim 2 , wherein delivering the active agent includes at least release of the active agent from the filled portion of the scaffold.
4. The method of claim 1 , wherein the interior reservoir contains at least a portion of the active agent.
5. The method of claim 4 , wherein the interior reservoir releases at least a portion of the active agent in response to a condition within the eye.
6. The method of claim 1 , wherein the scaffold comprises a coating comprising at least a portion of the active agent.
7. The method of claim 6 , further comprising releasing the active agent from the coating over time.
8. The method of claim 1 , wherein the active agent is delivered over a period of at least 6 months.
9. The method of claim 1 , wherein the active agent is delivered over a period of at least 1 year.
10. The method of claim 1 , wherein the flexible material is a polymer.
11. The method of claim 10 , wherein the polymer is selected from the group consisting of a polyimide, polyvinylidene fluoride, silicone, polytetrafluoroethylene, expanded polytetrafluoroethylene, differential fluoropolymer, fluorinated ethylene propylene, polyolefins, polypropylene, poly(methyl methacrylate), acrylic polymers, polyethylene terephthalate, polyethylene, polylactide, parylene, nylon, polyether ether ketone, polysulfone, polyamideimides, polyether block amides, polyurethanes, thermoplastic elastomers, liquid crystal polymers, and combinations thereof.
12. The method of claim 1 , wherein the flexible material is a metal.
13. The method of claim 12 , wherein the metal is selected from the group consisting of nitinol, platinum, stainless steel, molybdenum, gold, and combinations thereof.
14. The method of claim 1 , wherein the flexible material is a combination of metal and polymer.
15. The method of claim 1 , wherein said scaffold further comprises a chemical scaffold comprising the active agent.
16. The method of claim 15 , wherein the chemical scaffold comprises a polymeric gel.
17. The method of claim 16 , wherein the polymeric gel comprises a polysaccharide.
18. The method of claim 17 , wherein the polysaccharide has an average molecular weight of 700 kDa or greater.
19. The method of claim 17 , wherein the polysaccharide has an average molecular weight of 1000 kDa or greater.
20. The method of claim 17 , wherein at least two polysaccharides are cross-linked through carboxylic acid groups.
21. The method of claim 17 , wherein at least two polysaccharides are cross-linked through hydroxyl groups.
22. The method of claim 16 , wherein the active agent is released from the polymeric gel upon degradation of the polymeric gel.
23. The method of claim 15 , wherein the active agent is connected to the chemical scaffold by covalent bonding.
24. The method of claim 15 , wherein the active agent is ionically coupled to the chemical scaffold.